Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation
We review and compare our experience with tricuspid ring annuloplasty between usage of the Cosgrove-Edwards flexible band and the MC3 rigid ring for repair of functional tricuspid regurgitation to determine the efficacy and mid-term durability of tricuspid annuloplasty. 117 patients with functional tricuspid regurgitation undergoing open heart surgery and tricuspid valve repair from May 2005 to December 2007 were reviewed. The flexible bands were used in thirty five patients before October 2006. Since then, the rigid rings were used in the next consecutive eighty two cases. Echocardiographic evaluation of tricuspid regurgitation was performed preoperatively and postoperatively in followup schedule. The degree of tricuspid regurgitation was reduced from 2.80±0.67 to 0.71±1.0 (regurgitation severity grade: 0 to 4) in the patients with flexible bands at discharge It was from 2.68±0.70 to 0.22±0.60 in the patients with rigid rings. At thirty six months postoperative period, tricuspid regurgitation grades in patients with flexible bands and rigid rings were 0.80±0.95 and 0.36±0.77, respectively. Freedom from recurrent tricuspid regurgitation (grade 2 or 3) in patients with flexible bands and rigid rings were 68.6% and 87.8%, respectively. Recurrent tricuspid regurgitation was significantly lower in the patients with rigid rings. Although both flexible band and rigid ring annuloplasty provide low rate of recurrent tricuspid regurgitation, rigid ring annuloplasty might be more effective than flexible band annuloplasty for decreasing functional tricuspid regurgitation in immediate and mid-term postoperative periods.
Tricuspid valve, annuloplasty, valve heart valve.
Hironori Izutani, Associate professor, Department of Cardiovascular & Thoracic Surgery, Ehime University Graduate School of Medicine 454 Shitsukawa, Toon, Ehime 791-0295, Japan. E-mail: email@example.com
Share this Article
Related Content In Devices
Transcatheter Mitral Valve Replacement in Patients with Mitral Annular Calcification: A Review
Heart International. 2023;17(1):Online ahead of journal publication
Mitral valve (MV) disease includes either mitral regurgitation or mitral stenosis or both. The incidence and prevalence of valvular heart disease is increasing with the increasing population age. Degenerative MV disease poses a global burden with a prevalence of 18.1 million cases in 2017. Further, its global prevalence increased by 94% from 1990 to 2017.1 Surgery is the gold standard of […]
Current Status of Transcatheter Tricuspid Valve Therapies
Heart International. 2022;16(1):49–58 DOI: https://doi.org/10.17925/HI.2022.16.1.49
Tricuspid regurgitation (TR) is a complex disease with several independent causes. Consequently, outcomes and response to therapy vary widely. Severe or progressive TR often results in gradual right ventricular (RV) failure and is associated with poor long-term outcomes.1 Most cases of severe TR are secondary to left-sided heart disease, pulmonary hypertension or dilated cardiomyopathy, causing tricuspid […]
A Comprehensive Review of Mechanical Circulatory Support Devices
Heart International. 2022;16(1):37–48 DOI: https://doi.org/10.17925/HI.2022.16.1.37
Cardiogenic shock (CS) is a life-threatening condition characterized by cardiac pump dysfunction resulting in end-organ hypoperfusion and hypoxia.1,2 Although multiple treatment strategies have been explored in clinical trials, optimal therapy for CS is still debatable and mortality remains substantially high at around 50%.1 This need for improved treatment, together with a growing burden of patients with congestive […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!